Influence of physician, patient, and health care system characteristics on the use of outpatient mastectomy  by Shahbazi, Sara & Woods, Stephanie J.
The American Journal of Surgery (2016) 211, 802-809ReviewInfluence of physician, patient, and health care
system characteristics on the use of outpatient
mastectomySara Shahbazi, M.P.H.a,*, Stephanie J. Woods, Ph.D., R.N.baDepartment of Health Services Research, College of Health and Human Services, University of North
Carolina at Charlotte, 9201 University City Blvd, Charlotte, NC 28223-0001, USA; bSchool of Nursing,







Public policiesThe authors declare no conflicts of i
* Corresponding author. Tel.: 704-30
E-mail address: sshahbaz@uncc.edu
Manuscript received May 10, 2015;
2015
0002-9610/ 2016 The Authors. Publis
org/licenses/by-nc-nd/4.0/).
http://dx.doi.org/10.1016/j.amjsurg.20Abstract
BACKGROUND: Breast cancer is the 2nd leading cause of cancer deaths among women in the United
States. Breast cancer surgeries can be performed on either an inpatient or ambulatory basis. This sys-
tematic review of literature on outpatient mastectomy examines what is known about the factors that
influence the use of this procedure, existing public policies, and strategies to promote the appropriate
use of outpatient mastectomy.
METHODS: Factors associated with the utilization of outpatient mastectomy were categorized and
discussed under the following headings: ‘‘patient level,’’ ‘‘physician level,’’ and ‘‘system level.’’
RESULTS: Potential contributing factors to the use of outpatient mastectomy at the patient level
were race, educational level, comorbid conditions, cancer stage, and health insurance. Contributing fac-
tors at the provider level were demographics, surgeon specialty, and whether physician is an American
or international graduate. The associated factors at the system level were state policy and legislation
and hospital characteristics.
CONCLUSIONS: The evidence in the research literature suggests that the use of outpatient mastec-
tomy is a function of interactions between patient and physician characteristics, managed care influ-
ences, and the state policies and laws.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Breast cancer is the second leading cause of cancer
deaths among women in the United States (US) after lung
cancer. Breast cancer poses a huge medical and economic
burden for women and their families, and accounts from
15% to 20% of all cancer costs and 1% of the totalnterest.
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gical treatment of breast cancer has been described for cen-
turies. Historical analysis of this treatment reveals that the
efficiency and the extent of surgery has always been a
source of controversy.2 The primary treatment for nonme-
tastatic breast cancer (stages 0 to III) is surgery (breast con-
serving surgery [BCS] or mastectomy) to remove the
tumor. BCS, also known as lumpectomy, involves
removing only the breast lump and some normal tissue
around it. In contrast, mastectomy refers to removal of
the entire breast.3cess article under the CC BY-NC-ND license (http://creativecommons.
S. Shahbazi and S.J. Woods Outpatient mastectomy trends in the US 803Nowadays, breast cancer surgeries (including BSC and
mastectomy) can be performed on either an inpatient or
ambulatory basis. Outpatient procedures do not require an
overnight hospital stay and patients may go home several
hours after surgery. Previous literature documents that breast
cancer surgery including quadrantectomies, axillary lym-
phoadenectomies, simple or radical modified mastectomies,
and sentinel lymph node biopsies represents a good choice as
an outpatient procedure ‘‘when it is superficial and does not
imply any significant bleeding or electrolyte shifts.’’4
Moreover, previous studies show no evidence of differ-
ences in quality or outcomes of health care between
patients receiving outpatient breast cancer surgery
compared with those receiving inpatient surgery.5 Warren
et al conducted a large population-based study to explore
utilization trends and outcomes after outpatient mastectomy
(OM) in the US Their study included all women aged 65
and older in the fee-for-service Medicare program between
1986 and 1995. These researchers found that outpatients
and patients with a 1-day stay had nearly equal rates of re-
hospitalization for surgery-related complications.6 Rovera
et al4 evaluated the feasibility and efficacy of outpatient
breast cancer surgery and assessed its benefits. They inter-
viewed 88 women who were treated as outpatients at the
Department of Surgical Sciences, University of Insubria
in Varese, Italy from July 2003 to December 2006. Their
results showed the efficacy and the safety of the outpatient
procedures performed in an ambulatory setting. The re-
searchers found no intraoperative complications, and the
patients’ readmissions were due to nausea and emesis in
1 case, dyspnea (difficulty in breathing) in another case;
only 2 readmissions were due to surgical complications.4
Dravet et al7 indicated that women who had OMs tended
to experience fewer side effects and were more satisfied
with the procedure than patients who had been admitted
to the hospital after the surgery. In contrast, Bian et al8
found a negative association of OM with the use of breast
reconstruction, suggesting that the patients receiving OM
may not receive adequate postmastectomy care.
Previous studies also cite the psychological effects as
one of the greatest benefits for OM procedure. Dooley9 re-
ported from a study of 204 mastectomy patients between
1995 and 1997 that women who underwent OMs felt
more control over their recovery and treatment options.
McManus et al10 in a study addressing the surgical, finan-
cial, and psychosocial advantages of outpatient procedure
among 118 patients who underwent outpatient breast can-
cer surgery between 1991 and 1993, found that patients
had a high level of satisfaction with ambulatory surgery
and experienced faster healing and recovery at home within
the family milieu. Moreover, McManus et al confirmed the
cost effectiveness of outpatient breast cancer surgery vs
inpatient procedures. For eg, they found that outpatient
cost was $1,572 compared with an average 3-day inpatient
cost of $6,282, for a potential savings of $4,710, or 75%,
per patient for modified radical mastectomy. Outpatient
cost for lumpectomy with axillary node dissection was$1,080 compared with an average 2-day inpatient cost of
$4,907, for a potential savings of $3,827, or 78%, per pa-
tient.10 However, this study took place almost 20 years
ago, so the average costs and savings will differ today.
Multiple factors, including patient’s age, geographical
location, cancer stage, coexisting medical conditions, and
health insurance influence whether a patient will receive
surgical breast cancer procedures as an inpatient or an
outpatient.4 Most researchers in the field have concentrated
on inpatient and outpatient BCS procedures rather than
mastectomy. However, this article will focus exclusively
on mastectomy procedures as almost all BCS surgeries
are now being performed on an ambulatory basis.
Over the last decades, an extensive body of literature has
examined factors associated with the likelihood of
receiving BCS procedures among breast cancer patients.
However, limited research is available regarding the use of
OM. The purposes of this review are to: (a) examine the
factors contributing to OM; (b) identify patient character-
istics associated with having an OM, (c) examine the
physician factors related to the likelihood of receiving an
OM procedure; (d) identify the health care system charac-
teristics influencing the use of OM; and (e) discuss existing
public policies and identify a strategy that addresses
optimization of OM.Methodology
Reviewing process
The literature search for this systematic review was
completed using MEDLINE, PubMed, and Google Scholar.
Search terms included combinations of ‘‘OM,’’ ‘‘dispar-
ities,’’ ‘‘state policies,’’ ‘‘patient characteristics,’’ ‘‘physi-
cian characteristics,’’ and ‘‘hospital characteristics’’.
Reference lists of comprehensive review articles were
examined for relevant articles not available in MEDLINE,
PubMed, and Google Scholar searches. The full texts of all
the relevant articles were independently reviewed by the
authors. The methodological quality of the studies was
assessed using the Downs and Black checklist11 which was
designed for assessing study designs and has been found to
be valid and reliable for critically evaluating the quality of
both randomized and nonrandomized studies. The checklist
was modified to include specific questions related to the
outcome of the current review, for eg, some criteria were
removed because they were not appropriate for this review.
The modified checklist (Table 1) consists of 14 ‘‘yes’’ or
‘‘no’’ questions, including 7 general questions related to
the accuracy of outcome measures, data analysis, and inter-
nal and external validity of the selected studies and 7 spe-
cific questions related to the factors contributing to OM (ie,
characteristics of the patients, physicians, and healthcare
system, patient and/or physician preferences for surgical
choice, state policies regarding OM, type of insurance
and/or pay source, and type of ambulatory center in which



















Is the hypothesis/aim/objective of the study
clearly described?
Yes Yes Yes Yes Yes Yes Yes Yes Yes
Were the statistical tests used to assess the main
outcomes appropriate?
Yes Yes Yes Yes Yes Yes Yes Yes Yes
Are the main outcomes to be measured clearly
described in the Introduction or Methods
section?
Yes Yes Yes No No Yes Yes Yes Yes
Are the main findings of the study clearly
described?
Yes Yes Yes Yes Yes Yes Yes Yes Yes
Were the main outcome measures used accurate
(valid and reliable)?
Yes Yes Yes Yes Yes Yes Yes Yes Yes
Was there adequate adjustment for confounding
in the analyses from which the main findings
were drawn?
Yes No Yes Yes Yes Yes Yes Yes Yes
Were those subjects who were prepared to
participate representative of the entire
population from which they were recruited?
Yes No Yes No No No No Yes No
General Score 7 5 7 5 5 6 6 7 6
Are the characteristics of the patients, physician,
or system included in the study clearly
described?
Yes No Yes Yes Yes Yes Yes Yes Yes
Is it a comparative study (inpatient vs
outpatient)?
Yes No Yes Yes Yes No No Yes Yes
Is there information about all the breast cancers
operated on in the study period from which OM
patients were selected?
No No Yes No No Yes No Yes Yes
Are patient/physician preferences for surgical
choice addressed?
No No No No No No No No No
Were policies regarding OM for the state/states
under study discussed?
No No Yes No No No No Yes No
Was the type of insurance/pay source assessed? No No Yes No No Yes No Yes Yes
Was the type of ambulatory center in which
patients received OM noted?
No Yes Yes No No No Yes Yes No
Specific score 2 1 6 2 2 3 2 6 4
Range for general and specific score is 7.
OM 5 outpatient mastectomy.
804 The American Journal of Surgery, Vol 211, No 4, April 2016patients received the OM). From the checklists, studies
were then given a general score (based on the responses
to general questions) and a specific score (based on the re-
sponses to specific questions pertinent to objectives of this
review). Discrepancies in quality assessment and data
extraction were resolved through consensus discussion.
Outpatient mastectomy trends in the US. Ambulatory
surgery for mastectomy is not a new concept. This practice
has been shown to be safe and effective with equivalent
complication rates and high psychological satisfaction
when compared with in-patient hospital care.4,6–10 The
use of outpatient, so-called ‘‘drive-through’’, breast cancer
surgery increased rapidly in the US during the 1990s.8 Ac-
cording to Warren, the number of OMs, where surgery is
done without an overnight stay, increased from virtually
0% in 1986 (2 of 47,295 procedures) to 10.8% in 1995(4,831 of 44,940 procedures).6 During the same study
period, a decisive shift toward decreasing lengths of stay
for mastectomies occurred.6 From 1986 to 1988, 46.9%
of the total 117,982 mastectomy patients had a hospital
stay of 6 or more days. By 1993 to 1995, however, only
11% of the total 118,336 mastectomy patients had lengths
of stay of 6 or more days. Among the remaining patients
during that 2-year period, 18.6% stayed overnight or had
an outpatient procedure; 29.2% stayed 2 days; 22.5%
stayed 3 days; 12.6% stayed 4 days; and 6.3% stayed 5
days.6 This trend continued to from 1993 to 2000 where
the proportion of patients with breast cancer receiving
day surgery increased from 3.2% to 19.4% for mastectomy
and from 48.9% to 77.8% for BCS in the US.8
Contributing factors to OM. In the past, the suitability of
patients for outpatient procedures was based on tradition
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patient’s suitability for an ambulatory procedure is consid-
ered a dynamic process that depends on the complex inter-
play between patient characteristics (eg, coexisting medical
conditions), physician characteristics, and system character-
istics.1,2,6,13 Therefore, the decision about the appropriate
hospital length of stay after surgical treatment for breast can-
cer is made by the patient and her physician and in the
shadow of the current policies and legislation. Finding
from mastectomy studies identify several major factors as
contributors to OMprocedure. Review of the global literature
indicates that these factors can be categorized into 3 groups:
patient-level, physician-level, and system-level. All these
factors are described in detail in the following.
Patient-level
Previous literature has documented an association be-
tween patient characteristics and the likelihood of under-
going an OM.8 Patient characteristics, such as patient
preference, demographics, and overall health status, are
considered the primary predictors of patient selection for
ambulatory surgery processes.8 In this section, patient-
level factors related to the use of OM are discussed.
Patient preference. Patient preferences are powerful de-
terminants of breast cancer treatment and play an important
role in shaping the pattern of surgical treatment, especially
in the absence of a surgeon recommendation or influences
from insurance companies favoring 1 procedure over
another.14,15 Previous breast cancer studies have shown
that when both BCS and mastectomy procedures are medi-
cally appropriate, increased patient participation in surgery
decisions was associated with a higher likelihood of having
a mastectomy.16 However, there is almost no research ad-
dressing the association between patient preference and
use of OM, or the determinants of patient preferences for
inpatient vs OM. Moreover, patients, potential patients,
and cancer survivors can play a critical role in promoting
better policies regarding cancer care through advocacy.
For eg, they can help broaden the understanding of both
the scope and limitations of laws regarding OM procedure.
Although major advocacy campaigns, with appeals to the
legislatures, outlawing ‘‘drive-by mastectomy’’ raged
across the US 1 to 2 decades ago, no studies have directly
discussed the role of patients as advocates, or oppositions to
OM, or the OM-health insurance protection policies.
Age. Contradictory results have been reported in the
literature regarding the association between patient age
and utilization of OM. According to a 2003 Agency for
Healthcare Research and Quality’s (AHRQ) report, an OM
generally is recommended for young women.13 However,
some previous studies have reported higher rates of OM
procedure among women age 65 and over.8 Ferrante
et al,17 using state discharge abstracts and the state tumor
registry data, identified patients who have been diagnosedwith breast cancer and treated with mastectomies in Florida
in 1994 and found that OMs were more likely to be per-
formed on women age 65 and over. Warren et al6 found
no significant association between patient age and the like-
lihood of undergoing OM in their study. There is little
empirical literature looking at age and OM utilization in
middle-aged women.
Race. Disparities exist in the use of OM procedure among
racial minorities. Studies suggest that nonwhites are less
likely to receive OM than their white counterparts.8 Salasky
et al18 examined the differences in the use of OM based on
patient race. These researchers examined data from 47,318
patients enrolled in the American College of Surgeons
National Surgical Quality Improvement Program Partici-
pant Use File who had undergone a mastectomy during
the years 2007 to 2010. The authors indicated that more
than half (62.6%) of mastectomies were performed in the
outpatient setting. All racial minorities had lower rates of
OM, with 63.8% of white patients, 59.1% of African-
American patients, 57.4% of Asian, Native Hawaiian, or
Pacific Islander patients, and 43.9% of American Indian
or Alaska Native patients having had an OM. After adjust-
ing for multiple factors, African-American patients, Amer-
ican Indian or Alaska Native patients, and those of
unknown race were all less likely to undergo OM compared
with white patients.18 According to Warren et al,6 nonwhite
patients were also significantly less likely to undergo outpa-
tient modified radical mastectomy (removal of both breast
tissue and lymph nodes) than white patients.
Educational level. No studies were found that examined a
patient’s educational level as a predictor for the likelihood
of undergoing OM. There is a possibility that patients with
low educational level are more likely to undergo outpatient
procedures, as they usually have higher likelihood of being
uninsured compared with patients with advanced educa-
tional attainment.17 Nevertheless, it is impossible to
conclude this from the limited available research.
Comorbid conditions and cancer stage. In general, the
decision on outpatient or inpatient care should bemade on an
individual basis. For every patient, the nature of any pre-
existing condition, its stability, and functional limitation
needs to be evaluated.19Most previous studies suggested that
the patient’s medical conditions greatly influence the type of
procedure they receive.6 Researchers emphasized that pa-
tients with a high burden of comorbidities (such as hyperten-
sion or diabetes) or advanced and/or metastatic cancer are
more likely to have inpatient surgery whereas women
without these conditions are more likely to undergo OMs.6,8
For women with early-stage breast cancer, undergoing a
lumpectomy is as effective as having a mastectomy, and is
usually performed as an outpatient procedure. In a study by
Case et al, investigating the influence of payer and state on
the use of OM, cancer stage factor demonstrated an
important effect. The authors found that the adjusted
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woman had metastases.20 Bian et al8 also postulated that
patients with a higher stage of cancer at diagnosis were
more likely to receive inpatient surgery.
Health insurance. Although it is well established that the
OM procedure is medically safe and feasible, it may not be
appropriate for some patients. However, cost-conscious
insurance companies may limit a patient’s choice to OM
procedure to lower hospital costs,6 although, for some
women, an overnight stay is not enough to begin their phys-
ical and emotional healing.
A study conducted by the AHRQ, ‘‘outpatient mastec-
tomy: clinical, payer, and geographic influences’’, offers an
interesting insight regarding the impact of health insurance
on the use of OM procedure.20 The authors examined med-
ical records from 5 US states: Colorado, Connecticut,
Maryland, New Jersey, and New York between 1990 and
1996, and concluded that women without health insurance
or those who were Health Maintenance Organization mem-
bers were 30% to 60% more likely to undergo OM proce-
dures than women with health insurance, Medicare, or
Medicaid coverage. The researchers also examined the
trends and patterns for OM in the 5 states and found a sig-
nificant increase in the rate of OM in the late 1990s, in part
because of pressures from insurance companies during
those years to make OMs mandatory.20 In contrast, Ferrante
et al17 did not find any association between health insur-
ance type and having an OM. However, their findings
were consistent with other studies in showing higher rates
of OM among women without health insurance.17
Physician-level
Although patient demographics, health conditions, and
patient preference play an important role in determining the
suitability of this outpatient surgery, in almost all cases the
physician decides if the patient needs to be admitted as an
inpatient or outpatient for their mastectomy. Therefore, it is
important to examine the physician characteristics that influ-
ence the use of ambulatory procedures. In this section, several
physician-level factors related to the use of OM are discussed.
Physician demographics. Studies suggest that physician
demographics, such as age and gender, influence the
delivery of healthcare. For instance, according to Franks
and Bertakis,21 female family and general physicians in the
US and Canada are more likely to work in office-based
practices compared with their male counterparts, and there-
fore not have as much influence on the likelihood of having
an OM procedure. More evidence is needed to examine the
impact of gender on deciding the setting for a mastectomy.
Luther and Studnicki22 found that none of the physician de-
mographic variables proved to be significant in their inves-
tigation on selection of a surgical choice (mastectomy vs
BCS procedure) for breast cancer treatment the association
between surgeon volume.Surgeon volume. There is limited empirical literature
examining the relationship between the likelihood of hav-
ing an OM and surgeon volume (the number of procedures
performed by the surgeon). In a retrospective cross-
sectional analysis of 1997 to 1998 data from Florida
inpatient and outpatient settings, Luther and Studnicki22
found that the mastectomy rate was higher among patients
of low-volume surgeons compared with those of
high-volume surgeons, largely because high-volume sur-
geons were more likely to perform BCS rather than mastec-
tomy. However, their study did not show any significant
results for the relationship between surgeon volume and
likelihood of having an OM.22
Specialty board certification and surgeon specialization.
Medical specialty certification in the US is a voluntary
process. Board certification is widely recognized as a mark
of a physician’s exceptional expertise in a particular
specialty and/or subspecialty of medical practice and this
information is publicly available.23 A number of studies
have supported the validity of board certification as an in-
dicator of a specialist’s superior medical knowledge and
their high quality of care. Successfully passing board certi-
fication examinations have been positively associated with
physician clinical performance and patient care out-
comes.24 Sharp et al,25 in a systematic review of 33 studies
of physician certification and clinical outcomes published
between 1966 and 1999, found 16 studies demonstrating
a significant positive association between certification sta-
tus and positive clinical outcomes, 3 studies showing worse
outcomes for certified physicians, and 14 studies indicating
no association. However, limited evidence is available on
the relationship between the specialty board certification
and the utilization of ambulatory surgeries, including OM.
American or international medical graduate. To date, the
association between using ambulatory surgeries and
whether the physician had graduated from a US or foreign
medical school has received little attention. Luther and
Studnicki22 indicated that low-volume surgeons who were
more likely to perform a mastectomy rather than a BCS
procedure were more likely to have graduated from interna-
tional medical schools. Considering that most of the breast
cancer surgeries (both BCS and mastectomy) in their study
were performed in an outpatient setting, it could be sug-
gested that graduates of non-US medical schools are
more likely to perform OMs; however, more evidence is
needed to confirm this association.
System-level
State policy and legislation. Although patient and physi-
cian characteristics remain important, the state in which a
woman undergoes a complete mastectomy significantly
influences options related to surgical choice (outpatient vs
inpatient) for breast cancer treatment.18 Having a mastec-
tomy in an ambulatory setting has been a sensitive issue,
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states. States have been particularly active in passing laws
concerning breast cancer treatment, for eg, legislation
ending the practice of OM and/or BCS with lymph node
dissection.6,7 The growing popularity of outpatient breast
cancer surgery, particularly OM, began to attract wide-
spread public attention in the US in 1997, including warn-
ings against ‘‘drive-through’’ mastectomy. Since then, more
than 20 states in the US have passed laws mandating inpa-
tient coverage for breast cancer surgery.8
As outlined in the previous section, AHRQ researchers,
Case et al,20 conducted a study to examine the influence of
payer and state on the use of OM in light of state and fed-
eral length of stay managed care legislation in 5 states be-
tween 1990 and 1996. The researchers found that even after
controlling for payer, clinical, and hospital factors, the state
remains an important determinant of whether a woman can
receive an OM. In their study, women who received a mas-
tectomy in Colorado, Connecticut, Maryland, or New York
were anywhere from 1.3 to 8.6 times more likely to have an
outpatient procedure compared with women in New
Jersey.20 Furthermore, Bian et al8 in a study using 1993
to 2002 data from the Surveillance, Epidemiology and
End Results cancer registries and Medicare claims found
geographic variations and state laws significantly impacted
the likelihood of receiving an OM. Among Connecticut,
Hawaii, Iowa, New Mexico, and Utah, Utah had the highest
average annual proportion of OM (27.2%), whereas Con-
necticut had the lowest average annual proportion of OM
(3.9%) during the 10-year study period (4 years before
the passage of the law related to inpatient coverage for
breast cancer surgery in 1997).8
Hospital characteristics. Characteristics of the ambulatory
setting, such as free-standing vs hospital-based Ambulatory
Surgery Center, teaching vs nonteaching, and for-profit vs
nonprofit deserves special attention as it influences the ability
to manage complex patients based on the availabilities of
personnel and equipment. Warren et al indicated that OMs
weremore likely to be performed in for-profit or nonteaching
hospitals. Women treated in for-profit hospitals were 56%
more likely to have OM than women treated in nonprofit
hospitals.6 However, Case et al study indicated that the likeli-
hood of receiving anOMwas 60% lower in a publicly funded
hospital but this rate did not differ between private nonprofit
and for-profit hospitals. In addition, Case et al20 found that
women were less likely to receive an OM in teaching
compared with nonteaching hospitals. Further research is
needed to assess such discrepancies in findings and the
impact of hospital characteristics on the utilization of OM.
Existing public policies
The practice of outpatient breast cancer surgery has been
controversial in the US. Opponents of the outpatient proce-
dure allege increasedmanaged care as a contributing factor for
the growing rate of OM in the US, and express concerns thatby pressuring patients to undergo outpatient surgery,managed
care plans may take away the patient’s right of choice with
potentially detrimental implications for the quality and out-
comes of health care.26,27 Proponents, on the other hand,
counter that the choice of OM may offer a surgery delivery
setting better reflecting the preferences of patients and their
physicians and may not adversely affect the health outcomes
of women having outpatient breast cancer surgery.28
The public furor over OMs reached a peak in the US in
1997and attracted widespread public attention, including
warnings against ‘‘drive-through’’ mastectomy in the 1997
US. Presidential State of Union Address and the introduc-
tion of the Breast Cancer Patient Protection Act of 1997.
Since then, more than 20 states in the US have passed laws
mandating inpatient coverage for breast cancer surgery.8
One of the most famous existing public policies influencing
the use of OM is the Breast Cancer Patient Protection Act,
which prohibits insurance providers from limiting benefits
for any hospital length of stay to less than 48 hours for a
mastectomy or 24 hours for a lymph node dissection. It
does not require that the patient stay in the hospital for
the full 48 hours, only that the hospital stay be covered if
deemed essential by the patient’s surgeon.8
Strategies to Promote the Appropriate Use of
Outpatient Mastectomy. The actions taken on medical
issues are usually determined by the political lobbying
efforts of particular groups rather than by sensible medical
priorities and patient preferences. As a general rule, policy
makers and regulators support should be reserved for those
health policies that raise competition and promote the use
of service providing more affordable care, whereas main-
taining high quality care and stringent safety standards. In
light of the many benefits outpatient procedures, including
OM, have brought to the health care system, policy makers
should develop and implement policies that enhance access
to, and utilization of, ambulatory health care services. One
way to promote the appropriate use of OM might be to set
up an independent Advisory Council to provide input to
federal and state agencies regarding this sensitive public
policy issue or similar dubious subjects. It is crucial to
allow medical decisions, including the decision for selec-
tion of a surgical option, to be made by patients and
doctors, as opposed to insurers. There are women who are
satisfied with shorter lengths of hospital stay. However, for
some women, OM or less than 2 days of inpatient care after
surgery may not be safe. The primary goal of clinical
policies is to improve patient care. Yet, sometimes, patient
interests are not directly represented on guidelines panels
and the guidelines limit patient treatment options including
the choice of having inpatient vs outpatient procedures.Comments
The overall increase in ambulatory surgeries can be
explained primarily by 2 major factors. First, health care
808 The American Journal of Surgery, Vol 211, No 4, April 2016policies have created economic incentives that encourage
ambulatory surgery. Second, the efforts of managed care
organizations to minimize hospitalizations costs may have
influenced the increase in the rate of OM procedures.6 Most
of the literature on OM indicates that it is safe and effective
and an alternative to an inpatient procedure when a patient
is in good health has early-stage breast cancer, and the
physician confirms the suitability of the procedure. The ev-
idence in the research literature suggests that the use of OM
is a function of interactions between patient and physician
characteristics, managed care influences, and state policies
and laws. However, it is impossible to conclude from the
available evidence which one has the most impact on the
likelihood of undergoing OM. Patient race, education-
level, comorbid conditions, cancer stage, and health insur-
ance all act as contributing factors in determining the suit-
ability of OM for breast cancer patients. However, there is a
paucity of literature specially examining the relationship
between the use of OM and physician characteristics such
as demographics, volume, specialty board certification,
and graduation from a US or foreign medical school. State
policies and legislation as well as pressures by managed
care organizations to decrease costs are important determi-
nants of options for the type of setting where a woman can
receive her mastectomy.
This review provides important information for policy
makers and health systems managers as they evaluate,
legislate, and monitor the influence of federal and state
policies on the use of outpatient services. The article
provides policy makers with information on factors asso-
ciated with the use of OM and should be taken into account
in any debates in the area of outpatient regulation. Under-
standing these factors by health policy makers is important
in promoting the appropriate use of OM.
Although this systematic review of literature examined
information regarding the inter-related patient, physician,
and systems characteristics, much of the literature on OM is
10 or older. Current research is needed to establish the
quality of care and patient outcomes with OMs. Future
population-based research is needed to provide detailed
information on the role of physician characteristics as well
as differentiate the impact of the state policies and managed
care (insurance companies) and geographic location on the
use of the OM procedure. An additional limitation of this
review is that the available studies used inconsistent cancer
staging systems and definitions of progression, which
makes comparisons across studies difficult. Considering
that the stage of cancer is one of the most important factors
in choosing treatment, future population-based research is
needed to provide more precise information regarding
patient outcomes with the use of OM in studies with
similar cancer staging systems.
In conclusion, as the use of OM continues to grow, more
evidence-based studies are necessary to ensure patient
choice, safety, and health outcomes. The influences exerted
by managed care organizations on the patient and physi-
cians need to be carefully examined to make certain that alloptions of treatment are available for women in need of
breast cancer surgery. Policy makers and health systems
managers are invited to facilitate public debates and
deliberate using available research as they monitor and
legislate federal and state policies on the use of outpatient
services, particularly OM.References
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